Figure INF-6 HCV prevalence among injecting drug users – studies with national and subnational coverage, 2002 to 2003

Figure INF-06

Notes:

Black square, samples with national coverage; blue triangle, samples with local/regional coverage.

Differences between countries have to be interpreted with caution owing to different types of settings and/or study methods; national sampling strategies vary.

Data for Spain and Portugal and some of the data for Czech Republic include non-IDUs and therefore may underestimate prevalence among IDUs (proportion of non-IDUs in the samples not known).

Data for Portugal, Slovenia and Slovakie are limited to prevalence among IDUs in treatment and may not be representative of prevalence among IDUs who are not in treatment.

Sources:

Reitox national focal points (2004).

For primary sources, study details and data before 2002, see [Table INF-11] in the 2005 statistical bulletin.